Cary Adams, CEO of UICC, offers a look back at 2025 and ahead to 2026, with best wishes to members, partners, and the wider cancer community.
UICC welcomes the adoption of the long-awaited UN Political Declaration on NCDs and Mental Health, following several months of dialogue and advocacy. The declaration includes commitments on cancer, and its adoption now paves the way for countries to translate these commitments into national action.
UICC welcomes the adoption of the Political...
2025 World Cancer Leaders’ Summit united 400+ experts from 55 nations in Melbourne to advance global cancer control.
MAHAK, a UICC member in Iran who supports children living with cancer and their families, has developed a new digital application for fundraising, as part of a broader organisational shift within the organisation to replace older, traditional-based fundraising systems with digital tools that help sustain its work.
Digital innovation to fundraise and strengthen...
The new Executive Director of the Access to Oncology Medicines (ATOM) Coalition, Natasha Shah, outlines the work ahead to expand access to cancer care in low- and lower-middle-income countries through local partnerships, capacity-strengthening and effective pathways to innovative medicines.
Bristol Myers Squibb’s 2025 C2C4C Latin America ride ended on 9 December, wrapping up its C2C4C events, which included more than 300 Bristol Myers Squibb employees from 33 countries, each cycling nearly 360 kilometres. Bristol Myers Squibb is projected to donate over USD 2 million worldwide through the C2C4C events.
Bristol Myers Squibb’s C2C4C Latin America cycling...
Marking Universal Health Coverage (UHC) Day on 12 December, Sarbani of the UICC-led Access to Oncology Medicines (ATOM) Coalition writes about how innovative health financing strategies could transform access and equity under UHC in LMICs that face critical gaps in cancer care financing.